Shivendra Mani Tripathi | Pharmacology | Research Excellence Award

Research Excellence Award

Shivendra Mani Tripathi

Chhatrapati Shahu Ji Maharaj University, Kanpur, India

Shivendra Mani Tripathi
Affiliation Chhatrapati Shahu Ji Maharaj University, Kanpur
Country India
Scopus ID 58604443700
Documents 29
Citations 95
h-index 5
Subject Area Pharmacology
Event International Forensic Scientist Awards
ORCID 0000-0002-2531-9259

Shivendra Mani Tripathi is a researcher affiliated with Chhatrapati Shahu Ji Maharaj University, Kanpur, India, whose documented scholarly contributions are associated with pharmacology, therapeutic research, wound healing and advanced drug delivery. His publication portfolio reflects engagement with experimental investigations and review-based approaches to pharmaceutical science. His recent research addresses the therapeutic potential of medicinal plants, molecular perspectives on chronic pain and emerging nanotechnology-based approaches to transdermal drug delivery. These themes provide a basis for examining his research development and academic contribution in the context of the Research Excellence Award presented by the International Forensic Scientist Awards.

Abstract

Shivendra Mani Tripathi’s research profile demonstrates contributions to contemporary pharmaceutical sciences, particularly in therapeutic investigations and innovative drug delivery systems. His recent publications address wound healing using Lobelia inflata, the pharmacological mechanisms of terpenoids in chronic pain management and nanotechnology-enabled transdermal formulations. These research directions connect experimental pharmacology with emerging pharmaceutical technologies. His documented Scopus profile records 29 publications, 95 citations and an h-index of 5, indicating measurable scholarly activity and citation engagement. This recognition profile evaluates the relevance, thematic development and potential scientific value of his research contributions.[1]

Keywords

Pharmacology; Pharmaceutical Research; Wound Healing; Medicinal Plants; Terpenoids; Chronic Pain; Nanotechnology; Transdermal Drug Delivery; Nanoformulations; Therapeutic Development.

Introduction

Pharmacological research plays an important role in understanding therapeutic substances, investigating biological mechanisms and developing effective drug delivery approaches. Contemporary pharmaceutical science increasingly combines natural-product investigations with molecular pharmacology and formulation technologies. Within this evolving research environment, Tripathi’s recent publications demonstrate an interest in addressing different aspects of therapeutic development. His work encompasses experimental wound-healing research, the medicinal chemistry of bioactive compounds and advanced approaches for improving drug permeation through the skin. These subjects are relevant to ongoing efforts to improve pharmaceutical delivery, therapeutic effectiveness and patient-oriented treatment strategies.[2]

Research Profile

Tripathi’s documented research interests span several interconnected areas of pharmacological science. His publication on the therapeutic potential of Lobelia inflata examines wound healing in male Wistar rats, representing an experimental approach to investigating medicinal plant-based therapeutic applications. His contribution to research on terpenoids explores molecular pharmacology, neuroimmune modulation and advanced delivery strategies in the context of chronic pain. Additionally, his work on transdermal nanoformulations addresses technological approaches for improving drug permeation and controlled delivery.

The combination of these subjects illustrates an interdisciplinary research direction connecting pharmacognosy, therapeutic investigation, molecular mechanisms and pharmaceutical formulation development.

Research Contributions

Three recent publications provide important examples of Tripathi’s documented research engagement:

  • Medicinal plant-based wound healing: The study involving Lobelia inflata investigates its therapeutic potential in promoting wound healing through an animal-model research approach. It contributes to the exploration of natural products in experimental pharmacology.[3]
  • Terpenoids and chronic pain: The publication examines medicinal chemistry, molecular pharmacology and neuroimmune modulation, bringing together complementary perspectives on therapeutic research involving terpenoid compounds.[4]
  • Advanced transdermal formulations: This review addresses nanoscale carriers, smart delivery systems and strategies for enhancing drug permeation, highlighting the potential of pharmaceutical nanotechnology.[5]

Publications

The following selected publications illustrate the breadth of his recent scholarly activity:

  1. Therapeutic Potential of Lobelia inflata in Promoting Wound Healing in Male Wistar Rats. Current Bioactive Compounds, 2026. Published October 14, 2026.
  2. Medicinal chemistry of terpenoids in chronic pain: Molecular pharmacology, neuroimmune modulation, and advanced drug delivery strategies. Main Group Chemistry, 2026.
  3. Advances in Transdermal Nanoformulations: Smart Carriers for Enhanced Drug Permeation. Current Pharmacogenomics and Personalized Medicine, 2026.

Research Impact

According to the supplied Scopus author-profile information, Tripathi has published 29 documents, accumulated 95 citations and achieved an h-index of 5. These indicators provide quantitative evidence of his publication activity and scholarly visibility. His recent publications also demonstrate engagement with subjects relevant to pharmaceutical research, including natural-product therapeutics, chronic pain mechanisms and drug delivery innovation. The combination of experimental and review-oriented contributions supports the development of research knowledge across interconnected pharmacological disciplines. Citation indicators should be interpreted alongside publication quality, methodological relevance and the broader scientific contributions of individual studies.[1]

Award Suitability

The Research Excellence Award recognizes researchers demonstrating meaningful scholarly contributions, research engagement and subject-specific academic development. Tripathi’s publication record presents relevant evidence through his work in experimental pharmacology, medicinal chemistry and pharmaceutical nanotechnology. His research addresses both biological questions and technological approaches to therapeutic development. The diversity of his recent publications, together with his documented citation indicators, provides a basis for evaluating his academic contributions. His profile is therefore presented for recognition under the Research Excellence Award at the International Forensic Scientist Awards.

Conclusion

Shivendra Mani Tripathi’s research profile reflects continued engagement with pharmacological investigations and emerging pharmaceutical technologies. His contributions to medicinal plant research, chronic pain-related pharmacology and advanced transdermal delivery systems demonstrate a multidisciplinary approach to therapeutic science. Supported by his documented Scopus publication and citation indicators, these contributions establish a relevant academic foundation for consideration under the Research Excellence Award. His research activities illustrate the importance of integrating experimental investigations, scientific literature and innovative formulation strategies in advancing contemporary pharmaceutical research.

References

  1. Elsevier. (n.d.). Scopus author details: Shivendra Mani Tripathi, Author ID 58604443700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58604443700
  2. International Committee of Medical Journal Editors. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
  3. Tripathi, S. M., et al. (2026). Therapeutic Potential of Lobelia inflata in Promoting Wound Healing in Male Wistar Rats. Current Bioactive Compounds.
    https://doi.org/10.2174/0115734072521603261007035134
  4. Tripathi, S. M., et al. (2026). Medicinal chemistry of terpenoids in chronic pain: Molecular pharmacology, neuroimmune modulation, and advanced drug delivery strategies. Main Group Chemistry.
    https://doi.org/10.1177/10241221261498470
  5. Mishra, A. K., Sahoo, J., Ghosh, J. K., Sahoo, J., Singh, A. K., Pathak, S., and Tripathi, S. M. (2026). Advances in Transdermal Nanoformulations: Smart Carriers for Enhanced Drug Permeation. Current Pharmacogenomics and Personalized Medicine, 23.
    https://doi.org/10.2174/0118756921453701260724092348
  6. ORCID. (n.d.). Shivendra Mani Tripathi: Researcher Identifier 0000-0002-2531-9259.
    https://orcid.org/0000-0002-2531-9259
  7. International Forensic Scientist Awards. (n.d.). Official Award Website.
    forensicscientist.org

Leng Chee Chang | Pharmacology | Research Excellence Award

Prof. Dr. Leng Chee Chang | Pharmacology | Research Excellence Award

University of Hawaii at Hilo | United States

Prof. Dr. Leng Chee Chang is a natural products chemist whose work focuses on the isolation, characterization, and biological evaluation of bioactive compounds from medicinal plants, marine algae, and microbes with applications in cancer chemoprevention, chemotherapeutics, and antimicrobial discovery. According to Scopus-indexed records, she has authored 73 publications, which have been cited 2,567 times, reflecting a substantial global research impact. Her h-index of 28 highlights consistent scholarly influence and sustained citation performance across her body of work. Dr. Chang’s research has appeared in high-impact journals such as Organic Letters, Journal of Natural Products, Molecules, and ACS Omega, and encompasses multidisciplinary collaborations in pharmacognosy, medicinal chemistry, and pharmacology. Her work has contributed to the discovery of novel natural products with therapeutic potential.

                            Citation Metrics (Scopus)

3000

2500

2000

1500

1000

500

0

 

Citations
2567
Documents
73
h-index
28

Citations

Documents

h-index

View Scopus Profile

Featured Publications


A New Trichlorinated Xanthone and Compounds Isolated from Cladonia skottsbergii with Antimicrobial Properties

– Rositzki MJ, Raksat A, Simmons CJ, Smith C, Reverend Danette V. Choi, Wongwiwatthananukit S, Chang LC · Pharmaceuticals, 2026


Bioactive Constituents from the Edible Seaweed Halymenia hawaiiana (Rhodophyta)

– Raksat A, Atanu MSH, McDermimid KJ, Wall MW, Chang BL, Wongwiwatthananukit S, Chang LC · Pharmaceutical Biology, 2025


Bioactive Compounds from Dodonaea viscosa Flowers: Potent Antibacterial and Antiproliferative Effects in Breast Cancer Cells

– Raksat A, Yee D, Gi YJ, Wongwiwatthananukit S, Chang LK, Kaawaloa P, Wall MW, Chang LC · Molecules, 2025 (IF 4.2)


Biologically Active Withanolides from Physalis peruviana L.

– Sang-Ngern M, Fukuchi A, Kondratyuk TP, Park E-J, Simmons CJ, Wall MW, Lorch SE, Pezzuto JM, Chang LC · Pharmaceutical Biology, 2025


Vernonolide A, a Sesquiterpene Lactone with a Unique Carbon Skeleton from Vernonia cinerea

– Zhang M, Kondratyuk TP, Cao S, Li M, Songsak T, Wongwiwatthananukit S, Cai Y-S, Chang LC · Organic Letters, 2025 (IF 4.9)

 

Prabhat Singh | Pharmacology | Excellence in Research

Dr. Prabhat Singh | Neuroscience | Excellence in Research

Faculty of Pharmacy, Swami Vivekanand Subharti University | India

Dr. Prabhat Singh, a seasoned academic and researcher in the field of Pharmacology, currently serves as an Associate Professor at Kharvel Subharti College of Pharmacy, Swami Vivekanand Subharti University, Meerut. Born on July 8, 1988, Dr. Singh holds a B. Pharm., M. Pharm. (Pharmacology), and a Ph.D. His passion lies in advancing pharmaceutical education and scientific R&D. His academic dedication and research acumen have established him as a prominent figure in neuropharmacological research.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Dr. Prabhat Singh demonstrates a consistent and impactful research trajectory in the field of Neuropharmacology, Vascular Dementia, and Physiological Brain Conditioning. With over 22 peer-reviewed publications, several in high-impact journals such as Neurochemical Research, Current Neurovascular Research, and Central Nervous System Agents in Medicinal Chemistry, his work reflects both depth and innovation.

  • He has published research with a total international impact factor exceeding 31.8, an h-index of 9, and over 300 citations, highlighting growing academic recognition.

  • His exploration of novel pharmacological targets in ischemia-reperfusion brain injury and morphine withdrawal syndromes represents translational value in therapeutic strategies.

  • Dr. Singh has contributed significantly to scholarly literature through book publications (4 authored books), book chapters (3 in Nova Science Publishers, USA), and 6 IPRs on innovative healthcare technologies, including AI-powered medication systems and neurodegenerative disease detection devices.

  • As a Ph.D. supervisor to six scholars and mentor to eight M.Pharm students, he has actively nurtured the next generation of pharmaceutical researchers.

🎓 Education

Dr. Singh completed his Ph.D. in Pharmacology from Dr. APJ Abdul Kalam Technical University, Lucknow in 2022. He earned his M. Pharm. from Mahamaya Technical University, Noida with an impressive 81.78% in 2013 and his B. Pharm. from Uttar Pradesh Technical University in 2011 with 73.19%. His foundational education was completed under the Uttar Pradesh Board, achieving consistent academic performance. He is also a GPAT qualifier (2011) and actively contributes to university committees.

👨‍🏫 Experience

Dr. Singh has over a decade of teaching experience. Since February 2023, he has been working as an Associate Professor at Kharvel Subharti College of Pharmacy. Previously, he served as Assistant Professor at the same institution from 2016 to 2023 and at Kalka Institute for Research and Advanced Studies from 2013 to 2016. Additionally, he has industrial experience as a Product Sales Representative with Dr. Reddy’s Laboratories. He has guided 08 M. Pharm theses and is currently supervising 06 Ph.D. scholars.

🔬 Research Interests On Pharmacology

Dr. Singh’s research interests are deeply rooted in Neuropharmacology, with specific focus on vascular dementia, neurotoxicity, and physiological brain conditioning. His doctoral research involved novel pharmacological interventions during experimental ischemia-reperfusion brain injury. His work integrates behavioral neuroscience and biochemical analysis to explore therapeutic pathways in brain disorders.

🏆 Awards & Achievements

Dr. Singh is a committed academic with a strong track record of publication and intellectual property. He has authored four books, contributed to multiple book chapters published by Nova Science Publishers, and published six IPRs including innovations in AI-based medication systems and neurodegenerative disease detection devices. His cumulative journal impact factor exceeds 31.8, with an h-index of 9 and over 300 citations.

📚 Publications

  • Neuroprotective effects of agomelatine and vinpocetine against chronic cerebral hypoperfusion induced vascular dementia
    Authors: S Gupta, P Singh, B Mohan Sharma, B Sharma
    Year: 2015
    Citations: 73

  • Melatonin receptor and KATP channel modulation in experimental vascular dementia
    Authors: P Singh, S Gupta, B Sharma
    Year: 2015
    Citations: 45

  • Modulation of transient receptor potential vanilloid subtype 1 (TRPV1) and norepinephrine transporters (NET) protect against oxidative stress, cellular injury, and vascular …
    Authors: S Gupta, B Sharma, P Singh, B Mohan Sharma
    Year: 2014
    Citations: 40

  • Neuroprotective effects of nicorandil in chronic cerebral hypoperfusion-induced vascular dementia
    Authors: S Gupta, P Singh, B Sharma
    Year: 2016
    Citations: 26

  • Reversal in cognition impairments, cholinergic dysfunction, and cerebral oxidative stress through the modulation of ryanodine receptors (RyRs) and cysteinyl leukotriene-1 …
    Authors: P Singh, B Sharma
    Year: 2016
    Citations: 25

  • Selective serotonin-norepinephrine re-uptake inhibition limits renovascular-hypertension induced cognitive impairment, endothelial dysfunction, and oxidative stress injury
    Authors: P Singh, B Sharma
    Year: 2016
    Citations: 23

  • In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator
    Authors: P Singh, B Sharma, S Gupta, BM Sharma
    Year: 2015
    Citations: 22

  • Antiepileptic activity of aqueous extract of Tricosanthes dioica Roxb
    Authors: SG Prabhat Singh, Vipin K Garg, Pramod K Sharma
    Year: 2012
    Citations: 13

  • Plant bioactive compounds and their mechanistic approaches in the treatment of diabetes: a review
    Authors: Anshika, RK Pandey, L Singh, S Kumar, P Singh, M Pathak, S Jain
    Year: 2022
    Citations: 12

  • Antagonism of endothelin (ETA and ETB) receptors during renovascular hypertension-induced vascular dementia improves cognition
    Authors: P Singh, S Gupta, B Sharma
    Year: 2016
    Citations: 12

🧩 Conclusion

Dr. Prabhat Singh exemplifies academic excellence and research innovation in pharmacological sciences. With deep engagement in neuropharmacology, substantial teaching contributions, groundbreaking IPRs, and impactful publications, he continues to push the frontiers of pharmaceutical research and education. His commitment to scientific inquiry and student mentorship makes him a highly deserving candidate for this prestigious research award.